Did you experience any side effects after consuming the medication?
advertisement

Here is the some steps to help you to save money on 0.55 ML Methotrexate 50 MG/ML Auto-Injector purchase.


Read drug prescription

It is very important to know about what medicine is given by the doctor, for what condition, and when it needs to be taken in what dose. This information given by the doctor is called Prescription. The patients should be familiar with the medicine prescription, and the details about the medicine before purchasing it and using it. Some medications need not be prescribed by healthcare practitioners and can be purchased and used without prescription by the patients; these are called over-the-counter medications. Read the drug prescription information of 0.55 ML Methotrexate 50 MG/ML Auto-Injector before taking it.

What is 0.55 ML Methotrexate 50 MG/ML Auto-Injector

0.55 ML Methotrexate 50 MG/ML Auto-Injector interferes with the growth of certain cells of the body, especially cells that reproduce quickly, such as cancer cells, bone marrow cells, and skin cells.
0.55 ML Methotrexate 50 MG/ML Auto-Injector is used to treat certain types of cancer of the breast, skin, head and neck, or lung. 0.55 ML Methotrexate 50 MG/ML Auto-Injector is also used to treat severe psoriasis and rheumatoid arthritis.
0.55 ML Methotrexate 50 MG/ML Auto-Injector is usually given after other medications have been tried without successful treatment of symptoms.
0.55 ML Methotrexate 50 MG/ML Auto-Injector may also be used for purposes not listed in 0.55 ML Methotrexate 50 MG/ML Auto-Injector guide.

0.55 ML Methotrexate 50 MG/ML Auto-Injector side effects

Get emergency medical help if you have signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Stop using 0.55 ML Methotrexate 50 MG/ML Auto-Injector and call your doctor at once if you have:

Older adults may be more likely to have side effects from this medicine.
Common side effects may include:

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
See also: Side effects (in more detail)
advertisement

0.55 ML Methotrexate 50 MG/ML Auto-Injector dosing

Usual Adult Dose for Acute Lymphoblastic Leukemia:

Induction: 3.3 mg/m2/day orally or IM.
Maintenance (during remission): 15 mg/m2 IM or orally twice a week.
Alternate remission dosing: 2.5 mg/kg IV every 14 days.

Usual Adult Dose for Choriocarcinoma:

15 to 30 mg IM or orally daily for 5 days. Repeat courses 3 to 5 times with a rest period of greater than or equal to 1 week between courses, until any manifesting toxic symptoms subside.
Effectiveness of therapy is ordinarily evaluated by 24 hour quantitative analysis of urinary chorionic gonadotropin (hCG), which generally will return to normal or less than 50 intl units/24 hours usually after the third or fourth course and usually followed by a complete resolution of measurable lesions in 4 to 6 weeks. One to two courses of 0.55 ML Methotrexate 50 MG/ML Auto-Injector after normalization of hCG is usually recommended.

Usual Adult Dose for Trophoblastic Disease:

15 to 30 mg IM or orally daily for 5 days. Repeat courses 3 to 5 times with a rest period of greater than or equal to 1 week between courses, until any manifesting toxic symptoms subside.
Effectiveness of therapy is ordinarily evaluated by 24 hour quantitative analysis of urinary chorionic gonadotropin, which generally will return to normal or less than 50 intl units/24 hours usually after the third or fourth course and usually followed by a complete resolution of measurable lesions in 4 to 6 weeks. One to two courses of 0.55 ML Methotrexate 50 MG/ML Auto-Injector after normalization of hCG is usually recommended.

Usual Adult Dose for Lymphoma:

For Burkitt's tumor in Stages I-II: 10 to 25 mg orally once a day for 4 to 8 days
Malignant lymphoma in Stage III: 0.625 to 2.5 mg/kg orally daily as a part of combination chemotherapy.
Treatment in all stages usually consists of several courses of the drug interposed with 7 to 10 day rest periods.

Usual Adult Dose for Meningeal Leukemia:

12 mg/m2 intrathecally every 2 to 5 days until the cell count of the CSF returns to normal. At this point, one additional dose is advisable. Administration at intervals of less than 1 week may result in increased subacute toxicity.

Usual Adult Dose for Mycosis Fungoides:

2.5 to 10 mg PO daily or 50 mg IM once a week or 25 mg IM twice a week.

Usual Adult Dose for Osteosarcoma:

Initial Dose: 12 g/m2 intravenously as a 4 hour infusion. If this dose is not adequate to achieve a peak serum concentration of 1000 micromolar at the end of the infusion, the dose may be increased to 15 g/m2.
Treatments may occur at 4, 5, 6, 7, 11, 12, 15, 16, 29, 30, 44, and 45 weeks after surgery.
If the patient is vomiting or unable to tolerate oral medication, leucovorin should be added to this regimen at the same dose and schedule as the 0.55 ML Methotrexate 50 MG/ML Auto-Injector.

Usual Adult Dose for Psoriasis:

Single Dose: 10 to 25 mg/week orally, subcutaneously, IM, or IV until adequate response is achieved.
Divided Dose: 2.5 mg orally, IM, or IV every 12 hours for 3 doses once a week.
Maximum weekly dose: 30 mg.

Usual Adult Dose for Rheumatoid Arthritis:

Single dose: 7.5 mg orally weekly.
Divided dose: 2.5 mg orally every 12 hours for 3 doses once a week.
Maximum weekly dose: 20 mg
Patients may be switched from oral 0.55 ML Methotrexate 50 MG/ML Auto-Injector to weekly subcutaneous injections taking into account the increased bioavailability relative to the oral formulation.

Usual Adult Dose for Neoplastic Diseases:

I.V.: Range is wide from 30-40 mg/m2/week to 100-12,000 mg/m2 with leucovorin rescue

Usual Pediatric Dose for Acute Lymphocytic Leukemia:

100 mg/m2 over 1 hour followed by a 35 hour infusion delivering 900 mg/m2/day.

Usual Pediatric Dose for Dermatomyositis:

15 to 20 mg/m2 orally once weekly.

Usual Pediatric Dose for Meningeal Leukemia:

less than 4 months: 3 mg/dose intrathecally.
greater than or equal to 4 months less than 1 year: 6 mg/dose intrathecally.
greater than or equal to 1 year less than 2 years: 8 mg/dose intrathecally.
greater than or equal to 2 years less than 3 years: 10 mg/dose intrathecally.
greater than or equal to 3 years: 12 mg/dose intrathecally.
The dose may be administered every 2 to 5 days until CSF counts return to normal followed by a dose administered once weekly for 2 weeks and monthly thereafter. Administration at intervals of less than 1 week may result in increased subacute toxicity.

Usual Pediatric Dose for Neoplastic Diseases:

7.5 to 30 mg/m2 IM or orally every 2 weeks.
Alternate dosing: 10 to 18,000 mg/m2 IV bolus or continuous infusion over 6 to 42 hours.

Usual Pediatric Dose for Rheumatoid Arthritis:

5 to 15 mg/m2 IM or orally once weekly.
Subcutaneous injection for Polyarticular Juvenile Idiopathic Arthritis: 10 mg/m2 subcutaneously once weekly.

Usual Pediatric Dose for Solid Tumors:

less than 12 years: 12000 mg/m2 IV.
greater than or equal to 12 years: 8000 mg/m2 IV.
Maximum dose: 18 grams.

Select the most affordable brand or generic drug

Generic drug is the basic drug with an active substance in it, and the name of the generic drug is same as active substance most of the times. Like Acetaminophen/Paracetemol is Generic name and it has different brand names like Tylenol, Acimol, Crocin, Calpol etc. All these Brand names contain the same Paracetemol, but the medications are manufactured by different companies, so the different brand names. Generic drug is always cheaper and affordable, and it can be replaced in place of brand name drug prescribed by the healthcare practitioner. The Generic medicine has same properties as branded medicine in terms of uses, indications, doses, side effects, so no need to worry on that. Just select the most affordable generic or branded medicine.

StrengthQuantityPrice, USDCountry
Folitrax 25mg x 1mL AMP / 2ml $1.41
7 .5 mg x 10's $1.65
10 mg x 10's $2.10
15 mg x 10's $2.66
Folitrax 7.5mg x 1mL AMP / 1ml $0.28
Folitrax 7.5mg Injection $0.41Ipca Laboratories Ltd
Folitrax 20mg Tablet $0.49Ipca Laboratories Ltd
2 .5 mg x 10's $0.63
Folitrax 15mg Injection $0.65Ipca Laboratories Ltd
Folitrax 20mg Injection $1.00Ipca Laboratories Ltd
FOLITRAX tab 5 mg x 10's $1.19IPCA
2 .5mg10 $0.52
7 .5 mg x 10's $1.42
IMUTREX 7.5 MG TABLET 1 strip(s) (10 tablets each) $1.74Cipla Ltd
2 .5 mg x 10's $0.52
IMUTREX tab 2.5 mg x 10's $0.60Cipla
Imutrex 10mg TAB / 4 $0.75
2 .5mg100 Tablet$3.85
Methocel 500mg Injection $1.63Celon Laboratories Ltd
Methocel 2.5mg TAB / 10 $0.49
METHOCEL 500MG INJECTION 1 vial(s) (5 ML injection each) $8.13Celon Laboratories Ltd
METHOCEL 50MG INJECTION 1 vial(s) (2 ML injection each) $0.91Celon Laboratories Ltd
1 g x 1's $13.30
Methorex 2.5mg TAB / 10 $0.23
METHOREX inj 25 mg x 1 mL x 2ml $0.70Zydus (G.Rem)
100 mg x 1 mL x 10ml $12.10
15 mg3 ml$0.53
50 mg2 ml$0.85
15 mg3 ml$0.77
Mexate 10mg Tablet $0.16Zydus Cadila
250 mg x 10 mL x 1's $3.36
Mexate 2.5mg Tablet $0.06Zydus Cadila
Mexate 15mg x 1mL VIAL / 3ml $0.77
MEXATE 10 MG TABLET 1 strip(s) (4 tablets each) $0.91Zydus Cadila
Mexate 10mg TAB / 4 $0.98
Oncotrex 50 mg Injection $0.14
ONCOTREX tab 7.5 mg x 10's $1.60Sun
Oncotrex 10mg TAB / 10 $2.10
ONCOTREX 2.5 MG TABLET 1 strip(s) (10 tablets each) $0.63Sun Pharma Laboratories Ltd
Oncotrex 10mg/mL INJ / 5ml $0.71
Oncotrex 5mg Tablet $0.11Sun Pharmaceutical Industries Ltd
Pterin (vial) 25 mg/1 mL x 2 mL x 10's $42.84
Pterin 2.5 mg x 100's $15.40
Pterin tab 2.5 mg 100's $15.40Korea United Pharma
10 gm$1.53
Trexan 50 mg x 50's $272.30
Zexate 50 mg Injection $0.42
ZEXATE inj 5 mg x 1 mL x 3ml $0.70Fresenius Kabi
25 mg x 1 mL x 2ml $0.88
10 mg100 $306.00Australia, Canada, India, Mauritius, NZ, Singapore, Turkey, UK, USA
2 .5mg30 $37.00
2 .5mg100 $28.00Canada, India, NZ, Singapore, Turkey, UK, USA
2 .5mg100 $28.14Australia, Canada, India, NZ, Singapore, Turkey, UK, USA
2 .5mg100 $57.42Australia, Canada, NZ, Singapore, Turkey, UK, USA
2 .5mg100 $68.00Barbados, Canada, NZ, UK
25 mg100 $67.00Australia, Canada, India, Mauritius, NZ, Singapore, Turkey, UK, USA
25 mg/ml1 $95.00Australia, Canada, Mauritius, NZ, Singapore, Turkey, UK, USA
25 mg/ml30 $57.47USA
Ratio-Methotrexate Sodium 2.5 mg Tablet $0.66
Methotrexate Sodium 25 mg/ml (pf) Solution 2ml Vial $14.99
Methotrexate 10 mg Tablet $2.58
Methotrexate 5mg INJ $0.38
Trexall 5 mg tablet $8.66
2 .5mg10 $0.63
advertisement

References

  1. Dailymed."Rasuvo (methotrexate) injection, solution [medac pharma, inc]". https://dailymed.nlm.nih.gov/dailym... (accessed August 28, 2018).
  2. Dailymed."Methotrexate sodium: dailymed provides trustworthy information about marketed drugs in the united states. dailymed is the official provider of fda label information (package inserts).". https://dailymed.nlm.nih.gov/dailym... (accessed August 28, 2018).
  3. "Methotrexate". https://pubchem.ncbi.nlm.nih.gov/co... (accessed August 28, 2018).

0.55 ML Methotrexate 50 MG/ML Auto-Injector - Frequently asked Questions

Can 0.55 ML Methotrexate 50 MG/ML Auto-Injector be stopped immediately or do I have to stop the consumption gradually to ween off?

In some cases, it always advisable to stop the intake of some medicines gradually because of the rebound effect of the medicine.

It's wise to get in touch with your doctor as a professional advice is needed in this case regarding your health, medications and further recommendation to give you a stable health condition.

Who should not take 0.55 ML Methotrexate 50 MG/ML Auto-Injector?

You should not use this medicine if you are allergic to 0.55 ML Methotrexate 50 MG/ML Auto-Injector. Do not use 0.55 ML Methotrexate 50 MG/ML Auto-Injector to treat psoriasis or rheumatoid arthritis if you have:

0.55 ML Methotrexate 50 MG/ML Auto-Injector is sometimes used to treat cancer even when patients do have one of the conditions listed above. Your doctor will decide if this treatment is right for you.

To make sure 0.55 ML Methotrexate 50 MG/ML Auto-Injector is safe for you, tell your doctor if you have:

0.55 ML Methotrexate 50 MG/ML Auto-Injector can cause birth defects in an unborn baby. Do not use 0.55 ML Methotrexate 50 MG/ML Auto-Injector to treat psoriasis or rheumatoid arthritis if you are pregnant. Tell your doctor right away if you become pregnant during treatment.

You may need to have a negative pregnancy test before starting this treatment.

Use birth control to prevent pregnancy while you are using 0.55 ML Methotrexate 50 MG/ML Auto-Injector, whether you are a man or a woman. 0.55 ML Methotrexate 50 MG/ML Auto-Injector use by either parent may cause birth defects.

If you are a man, use a condom to keep from causing a pregnancy while you are using 0.55 ML Methotrexate 50 MG/ML Auto-Injector. Continue using condoms for at least 90 days after your treatment ends.

If you are a woman, use an effective form of birth control while you are taking 0.55 ML Methotrexate 50 MG/ML Auto-Injector, and for at least one cycle of ovulation after your treatment ends.

Do not give this medicine to a child without the advice of a doctor.

How should I take 0.55 ML Methotrexate 50 MG/ML Auto-Injector?

Follow all directions on your prescription label. Do not take this medicine in larger or smaller amounts or for longer than recommended.

You must use the correct dose of 0.55 ML Methotrexate 50 MG/ML Auto-Injector for your condition. 0.55 ML Methotrexate 50 MG/ML Auto-Injector is sometimes taken once or twice per week and not every day. Follow the directions on your prescription label. Some people have died after taking 0.55 ML Methotrexate 50 MG/ML Auto-Injector every day by accident. Ask your doctor or pharmacist if you have questions about your dose of 0.55 ML Methotrexate 50 MG/ML Auto-Injector or how often to take it.

Use 0.55 ML Methotrexate 50 MG/ML Auto-Injector regularly to get the most benefit. Get your prescription refilled before you run out of medicine completely.

0.55 ML Methotrexate 50 MG/ML Auto-Injector can lower blood cells that help your body fight infections and help your blood to clot. Your blood will need to be tested often, and you may need an occasional liver biopsy. Your cancer treatments may be delayed based on the results of these tests.

Store at room temperature away from moisture and heat.

What other drugs will affect 0.55 ML Methotrexate 50 MG/ML Auto-Injector?

Many drugs can interact with 0.55 ML Methotrexate 50 MG/ML Auto-Injector. Not all possible interactions are listed here. Tell your doctor about all your medications and any you start or stop using during treatment with 0.55 ML Methotrexate 50 MG/ML Auto-Injector, especially:

This list is not complete and many other drugs can interact with 0.55 ML Methotrexate 50 MG/ML Auto-Injector. This includes prescription and over-the-counter medicines, vitamins, and herbal products. Give a list of all your medicines to any healthcare provider who treats you.

Can 0.55 ML Methotrexate 50 MG/ML Auto-Injector be taken or consumed while pregnant?

Please visit your doctor for a recommendation as such case requires special attention.

Can 0.55 ML Methotrexate 50 MG/ML Auto-Injector be taken for nursing mothers or during breastfeeding?

Kindly explain your state and condition to your doctor and seek medical advice from an expert.

advertisement

Reviews

Following the study conducted by gmedication.com on 0.55 ML Methotrexate 50 MG/ML Auto-Injector, the result is highlighted below. However, it must be clearly stated that the survey and result is based solely on the perception and impression of visitors and users of the website as well as consumers of 0.55 ML Methotrexate 50 MG/ML Auto-Injector. We, therefore, urge readers not to base their medical judgment strictly on the result of this study but on test/diagnosis duly conducted by a certified medical practitioners or physician.

Patient reports

Patient reported useful

No survey data has been collected yet


Patient reported side effects

No survey data has been collected yet


Patient reported price estimates

No survey data has been collected yet


Patient reported frequency of use

No survey data has been collected yet


Patient reported doses

No survey data has been collected yet


Patient reported time for results

No survey data has been collected yet


Patient reported administration

No survey data has been collected yet


Patient reported age

No survey data has been collected yet


Patient reviews


There are no reviews yet. Be the first to write one!


Your name: 
Email: 
Spam protection:  < Type 28 here

The information was verified by Dr. Vishal Pawar, MD Pharmacology